Z-0470-2022 Class II Terminated
FDA device recall Z-0470-2022 was initiated by Reflexion Medical, Inc. on Nov 24, 2021 and is designated Class II. Reason for recall: Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS). The recall status is terminated (terminated Jul 8, 2024). Affected quantity: 3 devices.
Recall details
- Product Type
- Devices
- Report Date
- Jan 19, 2022
- Initiation Date
- Nov 24, 2021
- Termination Date
- Jul 8, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3 devices
Product description
RefleXion Medical Radiotherapy System - System Label: "*** refleXion REF RXM1000 ***" Physics Guide/Treatment Delivery User Manual/Treatment Planning User Manual: "RefleXion X1 Model: RXM1000"
Reason for recall
Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS).
Distribution pattern
U.S. Nationwide distribution in the states of CA and TX
Code information
Model: RXM1000 Serial Numbers/UDI Codes: X11001 / (01)00860003983805(11)210125(21)X11001 X11002 / (01)00860003983805(11)210324(21)X11002 X11003 / (01)00860003983805(11)210524(21)X11003
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0470-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026